Format

Send to

Choose Destination
See comment in PubMed Commons below
Digestion. 2005;71(1):26-8. Epub 2005 Feb 4.

Fistulizing Crohn's disease.

Author information

1
Division of Gastroenterology and Hepatology, Lausanne University Medical Center, Lausanne, Switzerland. Christian.Felley@hospvd.ch

Abstract

Fistulas are common in Crohn's disease. A population-based study has shown a cumulative risk of 33% after 10 years and 50% after 20 years. Perianal fistulas were the most common (54%). Medical therapy is the main option for perianal fistula once abscesses, if present, have been drained, and should include antibiotics (both ciprofloxacin and metronidazole) and immunomodulators. Infliximab should be reserved for refractory patients. Surgery is often necessary for internal fistulas.

PMID:
15711045
DOI:
10.1159/000083868
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for S. Karger AG, Basel, Switzerland
    Loading ...
    Support Center